Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.
about
Toxin-based therapeutic approachesAbrin triggers cell death by inactivating a thiol-specific antioxidant proteinAnti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma.BR96 sFv-PE40 immunotoxin: nonclinical safety assessment.Inroads in the therapy of indolent lymphomas: exploiting biological insights.Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8bMonoclonal antibody therapy for lymphoma: an update.The evolving role of monoclonal antibodies and dendritic cell therapy in hematologic malignancies.Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity.Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.The anti-CD19 antibody-drug conjugate SAR3419 prevents hematolymphoid relapse postinduction therapy in preclinical models of pediatric acute lymphoblastic leukemia.Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity.A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254.Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignanciesPhase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1P.Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.Bispecific monoclonal antibody therapy of B-cell malignancy.Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturation.Construction, expression, and characterization of BD1-G28-5 sFv, a single-chain anti-CD40 immunotoxin containing the ribosome-inactivating protein bryodin 1.Clinical targeting recombinant immunotoxins for cancer therapyPotent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID mice.The biological therapy of acute and chronic leukemia.Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview.Monoclonal antibodies in the treatment of human B-cell malignancies.
P2860
Q27013664-691680DC-EFB4-40D9-999B-9C1D1DDB6832Q28210339-D478E3E6-66EC-45DB-8CF2-0F7B1EBF31BBQ33503261-DDCD7CB4-7ADD-4075-9FE2-54B62308AC23Q33657671-2B927505-B751-4DF5-8268-6D0F8FD0E1C5Q34040863-9FB4358D-F7C9-4AED-9A18-BBF4AE51125CQ34116916-B42D63DB-FF49-4C3B-BAF2-5F122C9AFD77Q34552428-2ED6B507-750A-4FB3-8FBF-8B56BC46CDF6Q35173179-74C574B1-D95B-4414-A525-48C6DCCD4911Q35793141-ED9F0140-E067-43B2-8112-F5E1EB97CA7DQ36081770-75388B67-F5D4-47D4-858E-9C2026F6B8F5Q36745332-18F1DABE-A856-47C3-87B9-36F5A50BADF3Q36923799-1253045F-EE8D-4658-BE2F-232DCECEB6F9Q36929813-3490D9C1-37E8-4659-8E0E-1D7261A48262Q37165245-54F8636F-15C1-4833-ADEE-0AE65D9CBCF7Q37368203-F080EC8F-742F-40AA-B8B4-006CB43C9AACQ38262399-F4650F71-208A-4DF0-B094-A273EB17E6F1Q40507887-2A6ECAD0-1CA5-4BAC-BF3C-59C1552EB0FDQ40745587-D0D089C2-EF94-4549-8642-3D71F4669B8BQ41090092-38242739-5D86-4E21-8B13-D8F90A655541Q41149227-6A4A3B88-67EB-44A6-9D3B-2E41B39207CBQ41198251-AEFE268D-1805-4572-ACA8-F15D81687718Q41552414-DE173951-19EB-44EF-B540-F4843814944BQ50865525-979DB4DB-69D0-4851-A055-91E8B0E653B6Q51092788-F109EC74-2C90-4664-9C83-B54D1527A2DD
P2860
Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Anti-B4-blocked ricin: a phase ...... atients with B-cell neoplasms.
@en
type
label
Anti-B4-blocked ricin: a phase ...... atients with B-cell neoplasms.
@en
prefLabel
Anti-B4-blocked ricin: a phase ...... atients with B-cell neoplasms.
@en
P2093
P1476
Anti-B4-blocked ricin: a phase ...... patients with B-cell neoplasms
@en
P2093
C L Epstein
J A Taylor
J Kinsella
J M Lambert
N L Spector
V S Goldmacher
W A Blättler
P304
P356
10.1200/JCO.1993.11.4.726
P407
P577
1993-04-01T00:00:00Z